Glimiprime MP 1 mg/500 mg/15 mg Tablet
Marketer
Primus Remedies Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimiprime MP 1 mg/500 mg/15 mg Tablet
Metformin/glimepiride/pioglitazone 1mg/500mg/15mg tablets manage blood glucose in adults with type 2 diabetes. This triple-combination therapy, used alongside diet and exercise, enhances insulin effectiveness, reducing blood sugar. Dosage and frequency should strictly follow your physician's instructions; always take with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless the next dose is imminent; never double the dose to compensate. Excessive intake can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol consumption, or meal skipping raises hypoglycemia risk; regular blood glucose monitoring is essential. Common side effects include nausea, diarrhea, abdominal pain, headache, increased fracture risk, and respiratory infections. Patients with kidney, liver, or heart conditions, or those who are pregnant or breastfeeding must consult their doctor before starting this medication. Kidney function will be assessed prior to treatment commencement. Limit alcohol consumption due to increased side effect potential.
Primary Ingredients of Glimiprime MP 1 mg/500 mg/15 mg Tablet
No text provided. Please provide the text you would like me to rephrase.
Uses of Glimiprime MP 1 mg/500 mg/15 mg Tablet
Managing type 2 diabetes
Major Benefits of Glimiprime MP 1 mg/500 mg/15 mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Glimiprime MP 1 mg/500 mg/15 mg Tablet should be administered with a meal.
Common Side effects of Glimiprime MP 1 mg/500 mg/15 mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimiprime MP 1 mg/500 mg/15 mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the Glimiprime MP 1 mg/500 mg/15 mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.
How Glimiprime MP 1 mg/500 mg/15 mg Tablet works:
Glimiprime MP 1 mg/500 mg/15 mg tablets contain a triple-action formulation of glimepiride, metformin, and pioglitazone to manage blood sugar. This combination therapy offers enhanced glycemic control when monotherapy or dual-drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, reducing blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further enhances insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimiprime MP 1 mg/500 mg/15 mg tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Glimiprime MP 1 mg/500 mg/15 mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimiprime MP 1 mg/500 mg/15 mg tablets while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by abnormally low or high blood glucose levels. Refrain from driving if you experience such symptoms.
KidneyCAUTION
Patients with kidney impairment should use Glimiprime MP 1 mg/500 mg/15 mg tablets cautiously, potentially requiring dose modification. Severe kidney disease contraindicates use of this medication. Regular kidney function monitoring is recommended during treatment. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Glimiprime MP 1 mg/500 mg/15 mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Glimiprime MP 1 mg/500 mg/15 mg tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Glimiprime MP 1 mg/500 mg/15 mg Tablet :
Should you forget a dose of Glimiprime MP 1 mg/500 mg/15 mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimiprime MP 1 mg/500 mg/15 mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes medication |
3,018 People bought this recently